50737-34-3 Usage
Description
5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole is a heterocyclic chemical compound with a molecular formula of C5H7ClN2O. It features an oxadiazole ring fused with a chloromethyl and an ethyl substituent, making it a versatile intermediate in organic synthesis and a building block for the development of pharmaceuticals and agrochemicals.
Uses
Used in Pharmaceutical Industry:
5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole is used as a key building block for the synthesis of various pharmaceuticals. Its unique structure allows for the creation of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole is utilized as a component in the development of agrochemicals, contributing to the production of effective pesticides and other agricultural products.
Used in Organic Synthesis:
As a versatile intermediate, 5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole is used in organic synthesis for the development of new materials and compounds with a wide range of applications.
Used in Antimicrobial and Anti-fungal Applications:
Due to its potential biological activities, 5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole is studied for its antimicrobial and antifungal properties, which can be harnessed in various applications such as in medical treatments or as a preservative in different industries.
It is crucial to handle 5-(Chloromethyl)-3-ethyl-1,2,4-oxadiazole with care, as it is a potentially hazardous chemical that may cause harm if not managed properly.
Check Digit Verification of cas no
The CAS Registry Mumber 50737-34-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,7,3 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 50737-34:
(7*5)+(6*0)+(5*7)+(4*3)+(3*7)+(2*3)+(1*4)=113
113 % 10 = 3
So 50737-34-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H7ClN2O/c1-2-4-7-5(3-6)9-8-4/h2-3H2,1H3
50737-34-3Relevant articles and documents
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
-
Page/Page column 150-151, (2008/06/13)
The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
